Avammune Therapeutics Secures $12 Million in Series A Funding
Avammune Therapeutics secures $12 million in Series A financing to accelerate its proprietary pipeline.
Avammune Therapeutics secures $12 million in Series A financing to accelerate its proprietary pipeline.